These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10924735)

  • 21. Effects of doxazosin, an alpha 1-adrenergic inhibitor, on plasma lipid and lipoprotein levels, low density lipoprotein metabolism and cholesterol absorption in cynomolgus monkeys.
    Stucchi AF; Vespa DB; Terpstra AH; Nicolosi RJ
    Atherosclerosis; 1993 Nov; 103(2):255-66. PubMed ID: 8292100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein cholesterol uptake mediates up-regulation of bile-acid synthesis by increasing cholesterol 7alpha-hydroxylase but not sterol 27-hydroxylase gene expression in cultured rat hepatocytes.
    Post SM; Twisk J; van der Fits L; de Wit EC; Hoekman MF; Mager WH; Princen HM
    Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):339-46. PubMed ID: 10393091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status.
    Arai Y; Hirose N; Nakazawa S; Yamamura K; Shimizu K; Takayama M; Ebihara Y; Osono Y; Homma S
    J Am Geriatr Soc; 2001 Nov; 49(11):1434-41. PubMed ID: 11890580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G; Beltz WF; Grundy SM; Howard BV
    J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity.
    Rönnemaa T; Marniemi J; Savolainen MJ; Kesäniemi YA; Ehnholm C; Bouchard C; Koskenvuo M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2792-9. PubMed ID: 9709949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease.
    Nikkilä M; Solakivi T; Lehtimäki T; Koivula T; Laippala P; Aström B
    Atherosclerosis; 1994 Apr; 106(2):149-57. PubMed ID: 8060376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers.
    Liinamaa MJ; Kervinen K; Hannuksela ML; Kesäniemi YA; Savolainen MJ
    Alcohol Clin Exp Res; 1997 Jun; 21(4):606-12. PubMed ID: 9194912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
    Demant T; Bedford D; Packard CJ; Shepherd J
    J Clin Invest; 1991 Nov; 88(5):1490-501. PubMed ID: 1939641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Ikenoue N; Sagara Y
    Obstet Gynecol; 1997 Jul; 90(1):22-5. PubMed ID: 9207806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women have a larger and less atherogenic low density lipoprotein particle size than men.
    Nikkilä M; Pitkäjärvi T; Koivula T; Solakivi T; Lehtimäki T; Laippala P; Jokela H; Lehtomäki E; Seppä K; Sillanaukee P
    Atherosclerosis; 1996 Jan; 119(2):181-90. PubMed ID: 8808495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial.
    Vigna GB; Pansini F; Bonaccorsi G; Albertazzi P; Donegà P; Zanotti L; De Aloysio D; Mollica G; Fellin R
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):315-22. PubMed ID: 11302006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
    Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
    Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein metabolism in postmenopausal and oophorectomized women.
    Wakatsuki A; Sagara Y
    Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women.
    Welty FK; Lichtenstein AH; Lamon-Fava S; Schaefer EJ; Marsh JB
    Metabolism; 2007 Jul; 56(7):910-4. PubMed ID: 17570251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.